In this study, we provided considerable evidence to show that an anti-microtubule agent, ABT-751, induced profound anti-cancer effects, specifically the upstream cytostasis through the inhibition of SKP2 mRNA and its corresponding protein levels. Here, SKP2 is linked to cancer.